In Alzheimer’s disease, CCAAT/enhancer binding protein β/asparagine endopeptidase (C/EBPβ/AEP) signaling mediates disease progression by cleaving both β-amyloid precursor protein and Tau. The gene discussed is CEBPB; the disease is early-onset autosomal dominant Alzheimer disease.